Randomized trial · people

HCG: about 2 kg more lean mass but no strength gain in older men

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In older men with mildly low testosterone, 3 months of HCG raised testosterone and lean mass but did not translate into more strength or better physical function, and it shrank the testes.

Kind
Randomized trial
Studied in
People
Published
2002
Journal
J Clin Endocrinol Metab

What they tested

The researchers tested whether 3 months of recombinant HCG would improve muscle mass, strength, mobility and physical activity in older men with partial age-related androgen deficiency (mildly low testosterone), and whether it was safe.

How the study was done

A double-blind, randomized, placebo-controlled trial in men over 60 (mean age 67, range 60-85) who lived in the community, could walk on their own and had testosterone at or below 15 nmol/liter on two tests. They injected themselves under the skin twice a week with either recombinant HCG (5000 IU, 250 microg) or a placebo (a dummy shot) for 3 months, with check-ins monthly and once more 1 month after stopping.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking HCG? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Every man finished the study. HCG raised body weight by about 1 kg and lean body mass by about 2 kg, and cut fat mass by about 1 kg. Total and free testosterone and estradiol rose by 150% and stayed up, while LH and FSH fell and testis volume shrank by about 5 ml. Shoulder and knee strength, physical activity, gait and balance did not change, and neither did skinfold or body circumference measures; hemoglobin, PSA (a prostate blood marker) and prostate symptom scores held steady, and 3 men had nipple tenderness that did not progress to breast tissue growth.

What it doesn’t show

This was a small, short trial of 3 months in men over 60 with mildly low testosterone, so it can't show longer-term effects or how younger men or men with lower testosterone would respond. It tested a single dose given twice a week.

The paper

Liu et al. A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab. 2002.

The compound

More studies on HCG

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking HCG? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo